Skip to main content

Advertisement

SpringerLink
Log in

Hypertension in women

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

Abstract

Systolic blood pressure is higher in African American and Hispanic women older than 60 and in white women older than 70 than it is in men. Coupled with their longer survival, elderly women have higher hypertension prevalence rates, particularly for isolated systolic hypertension. Hemodynamic characteristics differ by sex for premenopausal women and age-matched men, but these differences lessen after menopause. This transition may result from hormonal or metabolic alterations, including weight gain and tissue adiposity, which are common after menopause. Clinical trials enrolling large numbers of women support the benefits of treatment to reduce cardiovascular events and mortality. The trend to enroll subjects with several comorbidities and thereby increase event rates may limit the applicability of trial results to healthier women. Women appear more prone to develop side effects from antihypertensive medications and may metabolize these agents differently. There is a need for additional studies regarding appropriate drug selection, dosage, and combination therapy for women.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Chobanian AV, Bakris GL, Black HR, et al.: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003, 42:1206–1252.

    Article  PubMed  CAS  Google Scholar 

  2. Ong KL, Cheung BM, Man YB, et al.: Prevalence, awareness, treatment, and control of hypertension among United States adults 1999–2004. Hypertension 2007, 49:69–75.

    Article  PubMed  CAS  Google Scholar 

  3. Lloyd-Jones DM, Sutton-Tyrrell K, Patel AS, et al.: Ethnic variation in hypertension among premenopausal and perimenopausal women: study of women’s health across the nation. Hypertension 2005, 46:689–695.

    Article  PubMed  CAS  Google Scholar 

  4. Messerli FH, Garavaglia GE, Schmieder RE, et al.: Disparate cardiovascular findings in men and women with essential hypertension. Ann Intern Med 1987, 107:158–161.

    PubMed  CAS  Google Scholar 

  5. Ashraf MS, Vongpatanasin W: Estrogen and hypertension. Curr Hypertens Rep 2006, 8:368–376.

    Article  PubMed  CAS  Google Scholar 

  6. Owens JF, Stoney CM, Matthews KA: Menopausal status influences ambulatory blood pressure levels and blood pressure changes during mental stress. Circulation 1993, 88:2794–2802.

    PubMed  CAS  Google Scholar 

  7. Safar ME, Smulyan H: Hypertension in women. Am J Hypertens 2004, 17:82–87.

    Article  PubMed  Google Scholar 

  8. Schmieder RE, Rockstroh JK, Aepfelbacher F, et al.: Gender-specific cardiovascular adaptation due to circadian blood pressure variations in essential hypertension. Am J Hypertens 1995, 8:1160–1166.

    Article  PubMed  CAS  Google Scholar 

  9. Kuch B, Muscholl M, Luchner A, et al.: Gender specific differences in left ventricular adaptation to obesity and hypertension. J Hum Hypertens 1998, 12:685–691.

    Article  PubMed  CAS  Google Scholar 

  10. Levy D, Larson MG, Vasan RS, et al.: The progression from hypertension to congestive heart failure. JAMA 1996, 275:1557–1562.

    Article  PubMed  CAS  Google Scholar 

  11. Gueyffier F, Boutitie F, Boissel J, et al.: Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. Ann Intern Med 1997, 126:761–767.

    PubMed  CAS  Google Scholar 

  12. Quan A, Kerlikowske K, Gueyffier F, Boissel J: Efficacy of treating hypertension in women. J Gen Intern Med 1999, 14:718–729.

    Article  PubMed  CAS  Google Scholar 

  13. Malmqvist K, Kahan T, Dahl M: Angiotensin II type 1 (AT1) receptor blockade in hypertensive women: benefits of candesartan cilexetil versus enalapril or hydrochlorothiazide. Am J Hypertens 2000, 13:504–511.

    Article  PubMed  CAS  Google Scholar 

  14. Chasan-Taber L, Willett WC, Manson JE, et al.: Prospective study of oral contraceptives and hypertension among women in the United States. Circulation 1996, 94:483–489.

    PubMed  CAS  Google Scholar 

  15. Woods JW: Oral contraceptives and hypertension. Hypertension 1988, 11(Suppl II):II-11–II-15.

    CAS  Google Scholar 

  16. Ehrmann DA: Polycystic ovary syndrome. N Engl J Med 2005, 352:1223–1236.

    Article  PubMed  CAS  Google Scholar 

  17. Gifford RW, August PA, Cunningham G, et al.: Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000, 183:S1–S22.

    Article  Google Scholar 

  18. Sibai BM: Treatment of hypertension in pregnant women. N Engl J Med 1996, 335:257–265.

    Article  PubMed  CAS  Google Scholar 

  19. von Dadelszen P, Ornstein MP, Bull SB, et al.: Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000, 355:87–92.

    Article  Google Scholar 

  20. von Dadelszen P, Magee LA: Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: an updated metaregression analysis. J Obstet Gynaecol Can 2002, 24:941–945.

    Google Scholar 

  21. Zhang J, Troendle JF, Levine RJ: Risks of hypertensive disorders in the second pregnancy. Paediatr Perinat Epidemiol 2001, 15:226–231.

    Article  PubMed  CAS  Google Scholar 

  22. Preston RA, White WB, Pitt B, et al.: Effects of drospirenone/17-B estradiol on blood pressure and potassium balance in hypertensive postmenopausal women. Am J Hypertens 2005, 18:797–804.

    Article  PubMed  CAS  Google Scholar 

  23. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al.: Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006, 354:2443–2451.

    Article  PubMed  CAS  Google Scholar 

  24. Elliott WJ, Meyer P: Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet 2007, 369:201–207.

    Article  PubMed  CAS  Google Scholar 

  25. Uhl K, Kweder S: Females in clinical studies: where are we going? Clin Pharmacol Ther 2007, 81:600–602.

    PubMed  CAS  Google Scholar 

  26. Dahlöf B, Devereux RB, Kjeldsen SE, et al.: Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002, 359:995–1003.

    Article  PubMed  Google Scholar 

  27. Bella JN, Palmieri V, Wachtell K, et al.: Sex-related differences in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study. J Hum Hypertens 2004, 18:411–416.

    Article  PubMed  CAS  Google Scholar 

  28. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981–2997.

    Article  Google Scholar 

  29. Wing LM, Reid CM, Ryan P, et al.: A comparison of outcomes with angiotensin-converting enzyme inhibitors and diuretics for hypertension in the elderly. N Engl J Med 2003, 348:583–592.

    Article  PubMed  CAS  Google Scholar 

  30. Black HR, Elliott WJ, Grandits G, et al.: Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003, 289:2073–2082.

    Article  PubMed  CAS  Google Scholar 

  31. Julius S, Kjeldsen SE, Weber M, et al.: Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet 2004, 363:2022–2031.

    Article  PubMed  CAS  Google Scholar 

  32. Julius S, Nesbitt SD, Egan BM, et al.: Feasibility of treating prehypertension with an angiotensin-receptor blocker. N Engl J Med 2006, 354:1685–1697.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street Southwest, Rochester, MN, 55905, USA

    Sandra J. Taler

Authors
  1. Sandra J. Taler
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandra J. Taler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Taler, S.J. Hypertension in women. Current Science Inc 11, 23–28 (2009). https://doi.org/10.1007/s11906-009-0006-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-009-0006-9

Keywords

Search

Navigation